Corixa and GlaxoSmithKline Respond to FDA; Complete Review Letter for BEXXAR.

Business WireMarch 25, 2002

Linked as:

Extract


Corixa and GlaxoSmithKline Respond to FDA; Complete Review Letter for BEXXAR.

Business Editors & Health/Medical Writers

BIOWIRE2K

SEATTLE & PHILADELPHIA--(BW HealthWire)--March 25, 2002

Corixa Corporation (Nasdaq:CRXA) and GlaxoSmithKline (NYSE:GSK), today announced that Corixa ha...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company